Coinjection of amyloid β peptide(25-35) and ibotenic acid does not create an animal model for Alzheimer's disease.

被引：0
|
作者：
Laksafoss, T [1 ]
Jorgensen, OS [1 ]
机构：
[1] Rigshosp 6102, Lab Neuropsychiat, DK-2100 Copenhagen, Denmark
来源：
EUROPEAN JOURNAL OF NEUROSCIENCE | 1998年 / 10卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
3232
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [1] β-amyloid peptide (25-35) as a tool for in vivo modelling Alzheimer's disease in rats
    Stepanichev, MY
    Onufriev, MV
    Moiseeva, YV
    Lazareva, NA
    Alessenko, AV
    Victorov, IV
    Gulyaeva, NV
    JOURNAL OF NEUROCHEMISTRY, 2001, 77 : 19 - 19
  • [2] Effect of adrenalectomy on nucleus Meynert neurons in amyloid-β 25-35 peptide-induced model of Alzheimer's disease
    Simonyan, K.
    Mnatsakanyan, V.
    Stepanyan, H.
    Chavushyan, V.
    Meliksetyan, I.
    Avetisyan, Z.
    Mnatsakanyan, H.
    JOURNAL OF NEUROLOGY, 2010, 257 : S64 - S64
  • [3] Effects of solvent on the structure of the Alzheimer amyloid-β(25-35) peptide
    Wei, Guanghong
    Shea, Joan-Emma
    BIOPHYSICAL JOURNAL, 2006, 91 (05) : 1638 - 1647
  • [4] Neuroprotective effects of salvianolic acid B on an Aβ25-35 peptide-induced mouse model of Alzheimer's disease
    Lee, Young Woo
    Kim, Dong Hyun
    Jeon, Su Jin
    Park, Se Jin
    Kim, Jong Min
    Jung, Jun Man
    Lee, Hyung Eun
    Bae, Shin Gil
    Oh, Hee Kyong
    Son, Kun Ho Ho
    Ryu, Jong Hoon
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 704 (1-3) : 70 - 77
  • [5] Interaction of the Alzheimer Aβ(25-35) peptide segment with model membranes
    Cuco, Andreia
    Serro, Ana Paula
    Farinha, Jose Paulo
    Saramago, Benilde
    da Silva, Amelia Goncalves
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 141 : 10 - 18
  • [6] Autoimmune responses to amyloid structures of Aβ(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease
    Grudena, MA
    Davudova, TB
    Malisauskas, M
    Zamotin, VV
    Sewell, RDE
    Voskresenskaya, NI
    Kostanyan, IA
    Shrestnev, VV
    Morozova-Roche, LA
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 18 (02) : 165 - 171
  • [7] Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions
    Waiter, MF
    Mason, PE
    Mason, RP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (03) : 760 - 764
  • [8] Interaction of Alzheimer's disease amyloid β peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain
    Pérez, M
    Cuadros, R
    Benítez, MJ
    Jiménez, JS
    JOURNAL OF ALZHEIMERS DISEASE, 2004, 6 (05) : 461 - 467
  • [9] Varenicline Ameliorates Learning and Memory Deficits in Amyloid beta(25-35) Rat Model of Alzheimer's Disease
    Baluchnejadmojarad, Tourandokht
    Roghani, Mehrdad
    Karimi, Narges
    Kamran, Mitra
    BASIC AND CLINICAL NEUROSCIENCE, 2011, 3 (01) : 48 - 57
  • [10] Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Aβ25-35 model of Alzheimer's disease
    Galoyan, Armen A.
    Sarkissian, John S.
    Chavushyan, Vergineh A.
    Meliksetyan, Irina B.
    Avagyan, Zaruhi E.
    Poghosyan, Mikhail V.
    Vahradyan, Hasmik G.
    Mkrtchian, Hovhannes H.
    Abrahamyan, Davit O.
    ALZHEIMERS & DEMENTIA, 2008, 4 (05) : 332 - 344
12345